About Myval
Myval is a company based in Vapi (India) founded in 1998. It operates as a B2B. The company has 1,428 employees. Myval operates in a competitive market with competitors including Silk Road Medical, HDL Therapeutics, Lifetech Scientific Corporation, Supira Medical and Shanghai Baixin'an Biotechnology, among others.
- Headquarter Vapi, India
- Employees 1,428
- SectorsHealthcare
- Website myval.com
- Employee Count1,428
Associated legal entities of Myval
Myval is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Meril Life Sciences Private Limited CIN U24239GJ2007PTC051137 | Active | 19 Jun 2007 | Vapi, Gujarat | ₹1,730 Cr | 1,584 | 4 | View details |
| Micro Life Sciences Private Limited CIN U24119GJ2006PTC048361 | Active | 31 May 2006 | Vapi, Gujarat | ₹4,992 Cr | 618 | 5 | View details |
| Bilakhia Holdings Private Limited CIN U67120GJ1992PTC017523 | Active | 29 Apr 1992 | Vapi, Gujarat | ₹3,664 Cr | 28 | 7 | View details |
Board of directors of Myval
The boards of the 3 registered companies of Myval currently have 12 directors; the longest-serving is Anjum Gafulbhai Bilakhia, appointed in 2000. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anjum Gafulbhai Bilakhia DIN 00171014 | Director | 03 Oct 2000 | 26 yrs | Bilakhia Holdings Private Limited |
| Yunus Gafulbhai Bilakhia DIN 00170981 | Director | 03 Oct 2000 | 26 yrs | Bilakhia Holdings Private Limited |
| Jakir Gafulbhai Bilakhia DIN 00171071 | Director | 01 Sep 2005 | 21 yrs 1 mo | Bilakhia Holdings Private Limited |
| Pramodkumar Minocha DIN 00090060 | Whole-time director | 31 May 2006 | 20 yrs 4 mo | Micro Life Sciences Private Limited |
| Nanubhai Premjibhai Bambharolia DIN 00089481 | Whole-time director | 19 Jun 2007 | 19 yrs 3 mo | Meril Life Sciences Private Limited |
| Rajnikant Gandalal Vyas DIN 00837447 | Whole-time director | 20 Oct 2010 | 15 yrs 11 mo | Meril Life Sciences Private Limited |
| Vivek Prafulbhai Shah DIN 03106944 | Whole-time director | 13 May 2021 | 5 yrs 5 mo | Micro Life Sciences Private Limited |
| Dinesh Saraf DIN 07256700 | Whole-time director | 01 Jan 2022 | 4 yrs 9 mo | Micro Life Sciences Private Limited |
| Hemchandra Yadunandan Panjikar DIN 07230533 | Director | 11 Mar 2023 | 3 yrs 7 mo | Meril Life Sciences Private Limited |
| Narendra Ostawal DIN 06530414 | Director | 15 Feb 2024 | 2 yrs 7 mo | Micro Life Sciences Private Limited |
| Lekhendra Nath Chaturvedi DIN 10359859 | Director | 01 Sep 2024 | 2 yrs 1 mo | Bilakhia Holdings Private Limited |
| Navinchandra Paragji Patel DIN 00175989 | Director | 01 Sep 2024 | 2 yrs 1 mo | Bilakhia Holdings Private Limited |
Financials of Myval
Figures of Micro Life Sciences Private Limited, the primary company behind Myval, for FY 2025. Revenue was ₹4,992 Cr (+40% year on year). Net profit was ₹729 Cr (15% margin). EBITDA was ₹1,284 Cr (26% margin).
- ₹4,992 CrRevenue · FY 2025 · +40% YoY
- ₹729 CrNet profit · 15% margin
- ₹1,284 CrEBITDA · 26% margin
- ₹5.00 CrPaid-up capital
- 618Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Micro Life Sciences Private Limited are on its company page.
Detailed financial statements for Myval
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Myval
Myval operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, HDL Therapeutics, Lifetech Scientific Corporation, Supira Medical and Shanghai Baixin'an Biotechnology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| silkroadmed.com | 2007 | Sunnyvale, United States | $241.8M | 352 | Provider of neuroprotection devices for carotid artery disease | |
| hdltherapeutics.com | 2010 | Short Hills, United States | $17.79M | – | Therapy to reverse coronary atherosclerosis is developed using patient plasma. | |
| lifetechmed.com | 1999 | Shenzhen, China | $66.2M | 44 | Interventional devices for cardiovascular and vascular diseases are developed. | |
| supiramedical.com | 2016 | Campbell, United States | $240.5M | – | Developer of ventricular assist devices for coronary intervention and cardiogenic shock | |
| bio-heart.com | 2014 | Pudong, China | $15.79M | – | A bioabsorbable coronary rapamycin-eluting stent system is developed using PLLA. | |
| avspulse.com | 2017 | Ann Arbor, United States | $70.45M | – | Pulsatile intravascular lithotripsy is developed for calcified arterial disease treatment. | |
| intershunt.com | 2015 | Louisiana, United States | $26.55M | – | Cardiac catheters for cardiac disease treatment are developed. | |
| s4medical.com | 2017 | Columbus, United States | $7.62M | – | Catheter ablation treatments for atrial fibrillation are developed. | |
| protaryx.com | 2019 | Baltimore, United States | $5.1M | – | Protaryx Medical is focused on developing transseptal access devices. | |
| medinol.com | 1992 | Tel Aviv, Israel | – | – | Thin cobalt-chrome stents are developed for coronary cardiovascular treatment. |
Detailed competitors of Myval
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Myval
Complete news archive for Myval
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Myval
10 companies that operate in the same segment as Myval (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Myval
Myval was founded in 1998.
Myval is headquartered in Vapi, India. It is registered at Vapi, Gujarat, India.
Myval has 1,428 employees.
Myval, established in 1998, excels in providing healthcare solutions, developing medical devices, cardiovascular, and valve replacement. Offers a transcatheter aortic heart valve replacement system. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Myval's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
Myval is associated with 3 legal entities: Micro Life Sciences Private Limited, Meril Life Sciences Private Limited, Bilakhia Holdings Private Limited.
The legal entities of Myval currently have 16 directors, including Vivek Prafulbhai Shah, Pramodkumar Minocha, Alpesh Mansukhlal Chaniyara and others.